EP2427216
USES OF IMMUNOCONJUGATES TARGETING CD138
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.5.2010EP published:
20.2.2019EP application number:
10718581.1
EPO information:
European Patent Register
Max expiry date:
4.5.2030
Title:
USES OF IMMUNOCONJUGATES TARGETING CD138
Timeline
Today
5.5.2010EP application
20.2.2019EP Publication
Owner
Name:
Biotest AGAddress:
Landsteinerstr. 5, 63303, Dreieich, DE
Name:
ImmunoGen, Inc.Address:
830 Winter Street, 02451, Waltham, MA, US
Inventor
Name:
OSTERROTH, FrankAddress:
Dietzenbach, DE
Name:
UHEREK, ChristophAddress:
Seligenstadt, DE
Name:
BRUECHER, ChristophAddress:
Eschborn, DE
Name:
DAELKEN, BenjaminAddress:
Frankfurt am Main, DE
Name:
ENGLING, AndréAddress:
Frankfurt, DE
Name:
HAEDER, ThomasAddress:
Dreieich, DE
Name:
WARTENBERG-DEMAND, AndreaAddress:
Schecksbach, DE
Name:
NIEMANN, GabrieleAddress:
Walzbachtal, DE
Name:
ZUBER, ChantalAddress:
Frankfurt, DE
Name:
CZELOTH, NiklasAddress:
Dreieich, DE
Name:
AIGNER, SilkeAddress:
Frankenthal, DE
Name:
ZENG, SteffenAddress:
Münster, DE
Name:
SCHULZ, GregorAddress:
Umkirch, DE
Priority
Number:
176069 PDate:
6.5.2009Country:
US
Number:
259430 PDate:
9.11.2009Country:
US
Classification
Categories:
A61K 47/68, A61P 35/02